Find clinical trials for Ovarian Cancer in Phoenix, AZ
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Phoenix, AZ, USA:
Gleolan for the real-time detection and visualization of epithelial ovarian cancer tumors during debulking surgery. The st...
Phase 3
Phoenix, Arizona, United States and 10 other locations
liposomal doxorubicin (PLD), and to compare the efficacy and safety of NP-G2-044+PLD vs. PLD alone in participants with platinum-resistant ovarian...
Phase 2, Phase 3
Phoenix, Arizona, United States and 5 other locations
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
Scottsdale, Arizona, United States and 46 other locations
efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...
Phase 2
Phoenix, Arizona, United States and 20 other locations
choice of chemotherapy in subjects with platinum-resistant ovarian cancer whose tumors are positive for cyclin E1 protein ...
Phase 3
Phoenix, Arizona, United States and 58 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Phoenix, Arizona, United States and 176 other locations
study is to compare how well Rina-S works against platinum-resistant ovarian cancer compared to chemotherapy drugs that are already ...
Phase 3
Scottsdale, Arizona, United States and 176 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...
Phase 3
Phoenix, Arizona, United States and 105 other locations
A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer....
Phase 2
Phoenix, Arizona, United States and 65 other locations
outcome of ADP A2M4CD8 as monotherapy and in combination treatment with nivolumab in human leukocyte antigen (HLA) A2+ subjects with recurrent ovarian...
Phase 2
Scottsdale, Arizona, United States and 22 other locations
Clinical trials
Research sites
Resources
Legal